The rapid inactivation of GLP-1 by the enzyme dipeptidyl peptidase IV (DPP-IV) within minutes prompted the development of GLP-1 analogs with prolonged half-lives, which are now approved for the treatment of T2DM and obesity (semaglutide, 160 h half-life)
A total WHITENING process of even tone with an INSTANT GLOW and SUPPLE you will experience
For example, after 2 years of treatment with liraglutide 2.4/3.0 mg in patients with obesity, 52% and 26% maintained at least 5% and at least 10% weight loss, respectively, compared with 29% and 16% of patients receiving orlistat [47] (Table 1)
This digestion process occurred overnight at 37 C
References Buse JB, Drucker DJ, Taylor KL, Kim T, Walsh B, Hu H, et al